Stock Events

Stock Events

C4 Therapeutics (CCCC) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.44

-0.36

-0.28

-0.2

Details

Expected EPS

-0.250629

Actual EPS

-0.2

Surprise EPS

0.05

Surprise Percent

+20.2%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.2 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.